Where to invest $50,000 in ASX shares

Analysts think these shares could be great destinations for your hard-earned money.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are lucky enough to be sitting on $50,000 and wondering how to put it to work in the share market, then read on.

With interest rates falling and long-term growth back in focus, now could be a great time to build a high-quality ASX share portfolio aimed at capital appreciation.

But rather than chasing short-term trades or speculative names, investors may want to consider businesses with proven track records, strong global expansion, and resilient earnings.

With that in mind, here are five standout ASX shares that analysts think could form the foundation of a smart, long-term portfolio. They are as follows:

A happy young couple lie on a wooden deck using a skateboard for a pillow.

Image source: Getty Images

Cochlear Ltd (ASX: COH)

Cochlear is a global leader in hearing implants technology. With an ageing global population and rising rates of hearing loss, demand for Cochlear's products is only expected to increase over the next decade. The company also invests heavily in R&D, which keeps it ahead of the pack with next-generation devices.

Last week, UBS upgraded its shares to a buy rating with a $325.00 price target.

REA Group Ltd (ASX: REA)

Another ASX share to look at with the $50,000 is REA Group. It is the name behind realestate.com.au, which dominates the online property advertising space in Australia. While the housing market moves in cycles, REA Group has built an incredibly sticky platform with pricing power and deep competitive moats.

Bell Potter is bullish on REA Group and has a buy rating and $267.00 price target on its shares.

ResMed Inc. (ASX: RMD)

ResMed is a major player in the treatment of obstructive sleep apnoea and other sleep and breathing disorders. While concerns around weight-loss drugs spooked the market last year, ResMed has continued to post strong results, including robust mask sales, margin expansion, and double-digit earnings growth. It also benefits from an ageing population and increasing awareness of sleep health.

Macquarie has an outperform rating and $48.00 price target on this ASX share.

WiseTech Global Ltd (ASX: WTC)

WiseTech could be an ASX share to buy with the $50,000. It is a global logistics software provider, best known for its CargoWise platform. It serves some of the world's largest freight forwarders and is capitalising on the structural shift toward digital supply chain management. Recurring revenue, global customer wins, and ongoing product innovation give WiseTech a long runway for growth.

The team at Macquarie has an outperform rating and $152.70 price target on its shares.

Xero Ltd (ASX: XRO)

Finally, Xero could be worth considering. It offers cloud-based accounting software to small and medium-sized businesses. It is one of the most recognisable tech names in the region, with a sticky, subscription-based model and strong international growth potential. And with 4.4 million subscribers on its platform and an estimated 100 million total addressable market, it still has a very long growth runway.

Morgan Stanley has an overweight rating and $220.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Cochlear, REA Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, Macquarie Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Three happy office workers cheer as they read about good financial news on a laptop.
Growth Shares

Are these the best ASX growth shares to buy and hold for 10 years?

Brokers rate these growth shares as buys in April. Here's what you need to know.

Read more »

A young man talks tech on his phone while looking at a laptop with a financial graph superimposed across the image.
Growth Shares

3 ASX growth shares to buy with $10,000

Looking to add some growth shares to your portfolio? Here are three that brokers rate as buys.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 ASX 300 shares that could be much bigger in 5 years

Big returns could be on offer from these shares according to analysts.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Growth Shares

3 ASX shares tipped to grow 75% or more in the next 12 month!

These businesses may be significantly undervalued.

Read more »

A woman looks excited as she holds Australian dollars in the air.
Growth Shares

2 undervalued ASX shares to buy that experts think could deliver strong returns

A fund manager thinks these ASX shares could deliver great returns.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Growth Shares

5 ASX growth shares to buy and hold for 5 years

These shares could be destined for bright futures.

Read more »

A woman with a magnifying glass adjusts her glasses as she holds the glass to her computer screen and peers closely at it.
Growth Shares

3 ASX shares below $5 with huge potential

Some of the most interesting ASX shares are not the biggest, but those still early in their growth journey.

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Growth Shares

This could be the best ASX 300 stock buy today!

This seems like a great time to invest.

Read more »